MEDANTA1,457.00

Global Health Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersMAXHEALTHAPOLLOHOSPFORTISGLAXOANTHEMAJANTPHARMIPCALABABBOTINDIAMcap ₹39,148 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations3,275.13,692.34,410.34,683.4
Other Income74.779.198.6100.4
Total Income3,349.83,771.44,508.94,783.8
Expenses
+ Cost of Materials Consumed687.7790.0882.1926.2
+ Purchases of Stock-in-Trade74.092.5117.3126.2
+ Changes in Inventories-2.3-2.8-2.6-0.4
+ Employee Benefit Expense734.9824.51,096.11,159.0
+ Finance Costs73.965.379.192.0
+ Depreciation & Amortisation172.7193.7222.5246.4
+ Other Expenses981.81,111.01,398.31,493.5
Total Expenses2,722.73,074.33,792.84,043.0
EBITDA799.1877.1919.1978.8
EBIT626.3683.3696.6732.3
Profit
PBT before Exceptional Items627.1697.2716.0740.8
+ Exceptional Items0.0-49.9-1.0-20.6
Pretax Income627.1647.3715.0720.1
+ Current Tax179.0161.6134.6145.3
+ Deferred Tax-29.94.426.422.5
Tax Expense149.0165.9160.9167.8
Net Income478.1481.3554.1552.3
+ Net Income — Continuing Ops478.1481.3554.1552.3
+ Other Comprehensive Income-0.9-0.73.6-1.8
Total Comprehensive Income477.1480.6557.7550.6
Net Income to Common478.2481.4556.5556.2
Minority Interest-0.1-0.1-2.4-3.8
Per Share
Basic EPS17.8017.9220.7120.70
Diluted EPS17.8017.9220.6620.67
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.73.6-1.8
+ Items NOT to be Reclassified to P&L-1.3-0.9
+ Tax on Items NOT to be Reclassified-0.2-5.11.6
+ Tax on Items NOT to be Reclassified — alt tag-0.3
+ Items to be Reclassified to P&L-0.2
+ Tax on Items to be Reclassified1.3
Comprehensive Income — Owners of Parent477.3-0.73.6-1.8
Comprehensive Income — Non-controlling Interests-0.10.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations17.8017.9220.7120.70
Diluted EPS — Continuing Operations17.8017.9220.6620.67
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,515.82,812.63,413.53,631.3
Gross Margin %76.8176.1877.4077.54
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)627.1697.2716.0740.8
− Exceptional Items (reconciliation)0.0-49.9-1.0-20.6
Net Income Adj (tax-effected)478.1518.4554.9568.1
EPS Adj17.8019.3020.7421.29
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital53.753.753.753.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.